DRUG NAME MECHANISM OF INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING

ACTION RESPONSIBILITIES

Aripiprazole is a Management Contraindicated with >Cerebrovascular >Inspect I.M.

Generic Name: partial agonist at of severely ill allergy to olanzapine, including stroke solution for
Aripiprazole D2 receptors. It schizophrenics myeloproliferative >Suicidal thoughts particulate matter
may act as an who are disorders, severe CNS and behaviors in and discoloration
Brand Name: antipsychotic by:  unresponsive depression, children before
Abilify >Lowering to standard comatose states and >Weight gain administration.
dopaminergic antipsychotic lactation. >Postural > Encourage
neurotransmission
Dosage: drugs. hypotension patient to void
in the mesolimbic
10-15mg P.O Reduction of >Extrapyramidal after taking the
pathway. 
400mg I.M. >Enhancing the risk of symptoms drug to help
dopaminergic recurrent >Lightheadedness decrease
activity in the suicidal >Drowsiness anticholinergic
mesocortical behavior in >Hyperglycemia effects of urinary
Route: pathway. patients with >Increased risk of retention.
- Oral schizophrenia hyperlipidemia > Monitor for
- I.M (not orally >Neuroleptic elevations of
disintegrating Malignant temperature and
Therapeutic tablet). Syndrome differentiate
Classification: >Tardive between infection
Atypical dyskinesia and neuroleptic
antipsychotic > Leukopenia malignant
drug > Neutropenia syndrome.
>Seizures >Monitor for
>Convulsion orthostatic
Pharmacologic >Suicide hypotension and
Classification: >Dysphagia provide
Second appropriate
Generation safety measures
antipsychotic as needed.
> Monitor patient
regularly for signs
and symptoms of
diabetes mellitus;
monitor lipid and
triglyceride levels.
> Peel back foil on
blister pack of
disintegrating
tablets; do not
push through foil;
use dry hands to
remove tablet,
place entire tablet
in mouth.